SMi reports: The upcoming Pain Therapeutics conference, taking place on the 13th and 14th May 2019, will gather expert speakers to address several industry-led themes.
SMi reports: Metys Pharmaceuticals, Ensysce Biosciences & AstraZeneca will be speaking and presenting at the 19th Annual Pain Therapeutics conference in London, this May.
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio